| Internet Electronic Journal of Molecular Design - IEJMD, ISSN 1538-6414, CODEN IEJMAT
 
| ABSTRACT - Internet Electron. J. Mol. Des. February 2005, Volume 4, Number 2, 124-150 |  | 
 Prediction of Intestinal Epithelial Transport of Drug in (Caco-2)
 Cell Culture from Molecular Structure using in silico
 Approaches During Early Drug Discovery
Yovani Marrero Ponce, Miguel A. Cabrera Pérez, Vicente Romero Zaldivar, Marival Bermejo Sanz, Dany Siverio Mota, and Francisco Torrens
 Internet Electron. J. Mol. Des. 2005, 4, 124-150
 
 |  Abstract:The high interest in the prediction of the intestinal absorption for
 new chemical entities is generated by the increasing rate in the
 synthesis of compounds by combinatorial chemistry and the
 extensive cost of the traditional evaluation methods. Novel
 molecular descriptors have been applied to estimate the intestinal
 epithelial transport of drug in Caco-2 cell culture. Total and local
 (atom and atom-type) quadratic indices used in this study were
 calculated by TOMOCOMD-CARDD software. Linear
 Discriminant Analysis (LDA) was used to obtain a quantitative
 model that discriminates the high absorption compounds (P ≥
 8×10-6 cm/s) from those with moderate-poor absorption (P <
 8×10-6 cm/s). A data set of 134 diverse structure drugs and two
 series of drugs-like compounds (12 compounds) were used as
 training and test set, respectively. In addition, Multiple Linear
 Regression (MLR) has been carried out to derive QSPerR
 models. All statistical analyses were performed with the
 STATISTICA software package. The obtained LDA model
 classified correctly 81.13% of compounds with moderate-poor
 absorption properties and the 96.30% of compounds with high
 absorption, showing a global good classification of 90.30% in the
 training set. The model showed a high Matthews' correlation
 coefficient (MCC = 0.80). Internal and external validation
 processes to demonstrate the robustness and predictive power of
 the obtained model were carried out. In this sense, the model
 classified correctly 87.31% (MCC = 0.73) in the leave-one-out
 cross-validation procedure. The discriminant model was also
 assessed by a 10-fold full cross-validation (removing
 approximately 13 compounds in each cycle, 85.82% of good
 classification), yielding a MCC of 0.70. Also this model shown
 an 87.5, 85.6, 84.7, 85.0, 85.3, 83.5, 84.1, 86.2, 85.9 and 85.9%
 of global good classification when n varied from 2 to 11 in the
 leave-n-out cross validation procedure. The model was stabilized
 around 85.9% when n was > 9. In addition, a data set of 7 HIV
 protease inhibitors (4 linear peptidomimetic and 3 new cyclic
 urea) and 5 new 6-fluoroquinolones derivatives was used as
 external test set. The LDA-QSPerR model achieved a MCC of
 0.71 (83.33% correct prediction) in this study. This approach
 permits us to obtain a good explanation of the experiment based
 on the molecular structural features, evidencing the main role of
 H-bonding and size properties in permeability process. Finally,
 the model developed was used in the virtual screening of 241
 drugs with the percentage of human intestinal absorption (Abs
 %) values reported. A relationship between the predicted
 permeability coefficients in Caco-2 and the Abs % (145
 compounds with good data quality) was established, with a
 percentage of good relation greater than 82 %. A comparison
 with results derived from other three theoretical studies shown a
 quite satisfactory behavior of the present method. All these
 results shown that total and local (atom and atom-type) quadratic
 indices can successfully predict intestinal permeability and
 suggest that the proposed methodology will be a good tool for
 studying the oral absorption of drug candidates during the drug
 development process.
 
 
 |